SATIOGEN PHARMACEUTICALS
Satiogen Pharmaceuticals is a specialty pharma company focused on novel-target for treating type 2 diabetes. The company's metabolic mechanism therapy offers designed to regulate nutrient intake and postprandial glucose. The company's products include a substitute for metformin in gliptin formulations and an OTC nutraceutical that would reduce body weight and postprandial glucose, enabling doctors to treat type 2 diabetes and obesity without intervention.
SATIOGEN PHARMACEUTICALS
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.satiogen.com
Status:
Active
Total Funding:
700 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart
Current Employees Featured
Founder
More informations about "Satiogen Pharmaceuticals"
SalioGen Therapeutics - Crunchbase Company Profile & Funding
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
SalioGen Therapeutics
SalioGen Therapeutics Thank you for visiting the website for SalioGen Therapeutics (“Company”), a next-generation genetic medicine company formerly based in Lexington, MA.See details»
SalioGen Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for SalioGen Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
SalioGen Therapeutics - Funding, Financials, Valuation & Investors
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
SalioGen Therapeutics Closes $115 Million Oversubscribed Series B ...
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — SalioGen Therapeutics, a privately held biotechnology company developing Gene Coding™, a new category of genetic medicine, …See details»
SalioGen Therapeutics - Overview, News & Similar companies
View SalioGen Therapeutics (www.saliogen.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
SalioGen Therapeutics Overview | SignalHire Company Profile
SalioGen Therapeutics is a biotechnology company on a mission to accelerate the impact of genetic medicine for patients using its novel Gene Coding™ technology. Gene Coding is a non …See details»
SalioGen raises $20M to validate non-viral gene …
Mar 1, 2021 SalioGen Therapeutics has raised $20 million to validate a platform designed to eliminate barriers to the use of gene therapies. The series A will support preclinical validation of mammal-derived ...See details»
Satiogen - Ownership and Business Overview | Mergr
May 23, 2022 Satiogen operates as a virtual company by outsourcing all activities required to validate the bile acid brake concept. Its focus has been on preclinical experiments for proof of …See details»
SalioGen Therapeutics - Craft
SalioGen Therapeutics is a company developing genetic medicine for patients with inherited disorders. It uses a genetic modification approach that works by adding a new genomic code …See details»
SalioGen Therapeutics, a gene-editing biotech company, is hit by ...
Oct 14, 2024 SalioGen Therapeutics, an organization that raised $135 million to develop a brand new gene-editing know-how, has instituted widespread layoffs and is scaling again its …See details»
SalioGen Therapeutics - Contacts, Employees, Board Members, …
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
Satiogen Pharmaceuticals, Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Satiogen Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
SalioGen Therapeutics - MassBio
Jan 26, 2022 SalioGen is advancing a new category of genetic medicine we call Gene Coding, which works by adding a new genomic code to turn on, off or modify the functions of new or …See details»
Cystic Fibrosis Foundation Announces Investment in SalioGen ...
Jan 5, 2022 About the Cystic Fibrosis Foundation The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than …See details»
SalioGen’s CEO on the company’s ‘Gene Coding ... - BiotechTV
May 7, 2024 Jason Cole describes how Gene Coding can deliver large sequences to the genome without viral vectors or RNA guides, and describes how these benefits translate to the …See details»
SalioGen Therapeutics hit by layoffs, as gene-editing biotechs
Oct 13, 2024 SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions.See details»
SalioGen Therapeutics - Tech Stack, Apps, Patents & Trademarks
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
Organization | Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Report issue For profit Phase 2 Founded: San Diego CA United States (2007) Status: Acquired by Mirum Pharmaceuticals, Inc. (2022) Organization Overview …See details»
VCs plow $115M into next-gen genetic medicine startup SalioGen, …
Jan 5, 2022 The most advanced candidates in SalioGen’s pipeline target the rare genetic eye disorder Stargardt disease and a trio of indications related to the liver: hypertriglyceridemia, …See details»